Clinical data | |
---|---|
Trade names | Psorcon |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602019 |
License data |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.872 |
Chemical and physical data | |
Formula | C26H32F2O7 |
Molar mass | 494.532 g·mol |
InChI
| |
(what is this?) (verify) |
Diflorasone diacetate is a topical steroid that comes in the form of a cream. It is manufactured by E. Fougera & Co. and is used as an anti-inflammatory and anti-itching agent, like other topical corticosteroids. It is prescribed for psoriasis and atopic dermatitis, among other conditions. With respect to potency, it is regarded as a Class I corticosteroid in the United States.
No long-term animal studies have been done to determine whether diflorasone diacetate could have carcinogenic properties.
Little data is available regarding whether diflorasone diacetate would be present in great enough quantities to cause harm to an infant.
References
- Shupack JL, Jondreau L, Kenny C, Stiller MJ (1993). "Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis". Dermatology. 186 (2): 129–32. doi:10.1159/000247323. PMID 8428041.
- "Topical Steroids Potency Chart". psoriasis.org.
- "Diflorasone topical". Drugs.com.
External links
- "Diflorasone diacetate". Drug Information Portal. U.S. National Library of Medicine.
Glucocorticoids and antiglucocorticoids (D07, H02) | |
---|---|
Glucocorticoids | |
Antiglucocorticoids |
|
Synthesis modifiers | |
|
This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it. |